Schwartz, J. E.Robertson, M. J.Cornetta, K. G.Cripe, L. D.Nelson, R. P.Yiannoutsos, C. T.Baute, J. A.Wood, L. L.Abonour, R.2022-12-082022-12-082006-02-01Schwartz, J. E., Robertson, M. J., Cornetta, K. G., Cripe, L. D., Nelson, R. P., Yiannoutsos, C. T., Baute, J. A., Wood, L. L., & Abonour, R. (2006). Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease. Biology of Blood and Marrow Transplantation, 12(2), 97–98. https://doi.org/10.1016/j.bbmt.2005.11.2981083-8791https://hdl.handle.net/1805/30681enAttribution-NonCommercial-NoDerivatives 4.0 Internationalrelapsed or refractory Hodgkin’s diseasecancer treatmentperipheral blood stem cells (PBSC)Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s diseaseArticle